why choose us

Clinical Trials Search

Showing 10,170 of 132,656 result(s)
Transform CV Risk in Diabetes

Status: Completed

Condition: Type 2 Diabetes

Interventions: This implementation strategy will include the clinician education of the previous arm and apply "audit and feedback" of prior care to inform

Date: 2023-07-06

Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years

Status: Completed

Condition: Diabetes

Interventions: The study compared patients taking different types of GLP-1(Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc) with taking placebo.

Date: 2023-07-06

Ventilation in Cardiac Arrest Resuscitation Study

Status: COMPLETED

Condition: Heart Arrest, Out-Of-Hospital

Interventions: Measurement of ventilatory parameters during manual ventilation by professional rescuers during out-of-hospital cardiac arrest

Date: 2023-07-06

Clinical Study of 18F-FAPI-RGD PET;CT in Rheumatoid Arthritis

Status: Completed

Condition: Rheumatoid Arthritis

Interventions:

Date: 2023-07-06

The Frequency of Beef Allergy in Children With Cow Milk Allergy

Status: Completed

Condition: Cow Milk Allergy

Interventions: It indicates if the child has allergy of Beef or not.

Date: 2023-07-06

Neural Prediction to Enhance Language

Status: Completed

Condition: Bilateral Sensorineural Hearing Loss

Interventions: The intervention will be taught by a qualified professional online and;or in-person for about 6 months.
Parents will learn strategies to enh

Date: 2023-07-06

Testing the ETM: Examination and Comparison of Different Methods

Status: NOT_YET_RECRUITING

Condition: Cigarette Smoking

Interventions: Exclusive cigarette smokers will be recruited and will be exposed to the real ETM condition in which tobacco purchases are real and they receive produ

Date: 2023-07-06

Deconstructing Post Stroke Hemiparesis

Status: Completed

Condition: Stroke

Interventions:

Date: 2023-07-06

OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer

Status: Completed

Condition: Triple Negative Breast Cancer (TNBC)

Interventions: Combination of liposomal doxorubicin 30 milligrams per square meter and carboplatin (area under the curve 5), administered every 4 weeks for 4 cycles.

Date: 2023-07-06

Hepatic Transplantation Registry

Status: Completed

Condition: Identify More Accurate Predictive Models of Transplant Risk to Monitor and Evaluate New and Existing

Interventions: Identify more accurate predictive models of transplant risk

Date: 2023-07-06